- Amgen CFO Peter Griffith will retire; Thomas Dittrich returns July 1 as EVP and assumes CFO duties on Sept 1, 2026.
- Griffith will remain through January 2027 to support the transition.
- Dittrich, with 30+ years of international finance experience, previously served as CFO at Galderma, Shire and Sulzer and will oversee Amgen's financial operations.
Leadership change
Peter Griffith, Amgen's executive vice president and chief financial officer since 2020, has announced his retirement; Thomas Dittrich will return to Amgen as executive vice president on July 1 and succeed Griffith as chief financial officer effective September 1, 2026.
Transition plan
Griffith will remain with the company through January 2027 to support a seamless transition and hand over financial responsibilities to Dittrich.
Successor background
Dittrich brings more than 30 years of international finance leadership, previously held senior finance roles at Amgen, served most recently as CFO of Galderma, and earlier as CFO at Shire and Sulzer; he will oversee all aspects of Amgen's financial operations.
Outgoing CFO's impact
During his tenure Griffith strengthened Amgen's financial foundation, supported disciplined capital allocation and helped advance the company's long-term growth strategy.
